Cytochrome P450 pathways of arachidonic acid metabolism

Current Opinion in Lipidology

Volumn 13, Issue 3, 2002, Pages 273-283

  Kroetz, Deanna L ^a   Zeldin, Darryl C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; DIHYDROXYICOSATRIENOIC ACID; EPOXYICOSATRIENOIC ACID; HYDROXYEICOSATETRANOIC ACID; ICOSATETRAENOIC ACID; UNCLASSIFIED DRUG; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; HYDROXYICOSATETRAENOIC ACID; MIXED FUNCTION OXIDASE;

APOPTOSIS; ARACHIDONIC ACID METABOLISM; CALCIUM CONDUCTANCE; CELL PROLIFERATION; CELL SPECIFICITY; DRUG POTENCY; ENZYME MECHANISM; ENZYME METABOLISM; HEMOSTASIS; INFLAMMATION; ION TRANSPORT; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REVIEW; STEREOISOMERISM; TISSUE SPECIFICITY; ANIMAL; DRUG ANTAGONISM; HUMAN; METABOLISM;

ANIMAL; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; HUMAN; HYDROXYEICOSATETRAENOIC ACIDS; MIXED FUNCTION OXYGENASES; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

EID: 0035985704     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200206000-00007     Document Type: Review

References (120)

1. Biochemical and molecular characteristics of the cytochrome P450 arachidonic acid monooxygenase
2. Cytochrome P450 and arachidonic acid bioactivation: Molecular and functional properties of the arachidonate monooxygenase
3. Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids
4. Cytochrome P450 metabolites of arachidonic acid in the control of renal function
5. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure
6. Epoxygenase pathways of arachidonic acid metabolism
7. Epoxygenase metabolites: Epithelial and vascular actions
8. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid
9. Identification, functional characterization, and regulation of a new cytochrome P450 subfamily, the CYP2Ns
10. Endogenous epoxyeicosatrienoic acids: Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase
11. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs
12. Synthesis of arachidonic acid-derived lipoxygenase and cytochrome P450 products in the intact human lung vasculature
13. Determination of EETs using microbore liquid chromatography with fluorescence detection
14. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid
15. Study of effects of dexamethasone treatment on arachidonic acid epoxygenases in rats using ELISA
16. Is EDHF an epoxyeicosatrienoic acid?
17. Cytochrome P450 2C is an EDHF synthase in coronary arteries
18. Cytochrome p450 and vascular homeostasis
19. Endothelium-derived relaxing factors: A focus on endothelium-derived hyperpolarizing factor(s)
20. Identifying endothelium-derived hyperpolarizing factor: Recent approaches to assay the role of epoxyeicosatrienoic acids
21. + channels in isolated rat coronary arterial myocytes
22. Ca channels
23. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs
24. Role of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factor in bovine coronary arteries
25. P-450 epoxygenase and NO synthase inhibitors reduce cerebral blood flow response to N-methyl-D-aspartate
26. Dual regulation of the cerebral microvasculature by epoxyeicosatrienoic acids
27. Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance
28. Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR
29. Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid
30. Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole
31. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin
32. Cytochrome P450 metabolites of arachidonic acid but not cyclooxygenase-2 metabolites contribute to the pulmonary vascular hyporeactivity in rats with acute Pseudomonas pneumonia
33. Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries
34. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation
35. Cytochrome P450 2C is an EDHF synthase in coronary arteries
36. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries
37. 11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle
38. Ca channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid
39. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
40. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators
41. Reply: Cytochrome P450-derived eicosanoids and the vascular wall
42. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells
43. s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids
44. Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary artery
45. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries
46. Cerebral microvascular endothelial cell tube formation: Role of astrocytic epoxyeicosatrienoic acid release
47. 3 cells
48. Ca channel activation and hyperpolarization
49. Arachidonic acid modulation of alpha1H, a cloned human T-type calcium channel
50. Cytochrome P450 CYP2J9, a new mouse arachidonic acid ω-1 hydroxylase predominantly expressed in brain
51. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids
52. + transport by angiotensin II in primary renal cells
53. Cytochrome p450-dependent metabolites of arachidonic acid and renal function in the rat
54. Selective inhibition of arachidonic acid epoxidation in vivo
55. Role of cytochrome P-450 in endogenous antipyresis
56. Hypothalamic 11,12-epoxyeicosatrienoic acid attenuates fever induced by central interleukin-1β in the rat
57. Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes
58. 2+ channels and contraction in mammalian heart cells
59. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes
60. Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect
61. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis
62. Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells
63. Overexpression of C-terminal Src kinase blocks 14,15-epoxyeicosatrienoic acid-induced tyrosine phosphorylation and mitogenesis
64. The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells
65. Mechanism and signal transduction of 14 (R),15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes
66. Conversion of epoxyeicosatrienoic acids (EETs) to chain-shortened epoxy fatty acids by human skin fibroblasts
67. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells: Implications for the vascular effects of soluble epoxide hydrolase inhibition
68. Binding of cytochrome P450 monooxygenase and lipoxygenase pathway products by heart fatty acid-binding protein
69. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney
70. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
71. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
72. Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: Relationship with sudden infant death syndrome
73. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
74. Cloning of the CYP2J2 gene and identification of functional polymorphisms
75. Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms
76. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11
77. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney: Role of CYP4F2 and CYP4A11
78. 4 ω-hydroxylase P450 (CYP4F2)
79. cDNA cloning and expression of a novel cytochrome P450 (CYP4F12) from human small intestine
80. cDNA cloning and expression of CYP4F12, a novel human cytochrome P450
81. Cloning and expression of a pig liver taurochenodeoxycholic acid 6α-hydroxylase (CYP4A21): A novel member of the CYP4A subfamily
82. Covalently linked heme in cytochrome P4504A fatty acid hydroxylases
83. Covalent linkage of prosthetic heme to CYP4 family P450 enzymes
84. Molecular cloning and regulation of expression of two novel mouse CYP4F genes: Expression in peroxisome proliferator-activated receptor α-deficient mice upon lipopolysaccharide and clofibrate challenges
85. Alternative splicing determines the function of CYP4F3 by switching substrate specificity
86. Cytochrome P-450-dependent HETEs: Profile of biological activity and stimulation by vasoactive peptides
87. Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid
88. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme
89. Discovery of a N′-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor
90. CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR
91. Abnormal pressure-natriuresis in hypertension: Role of cytochrome P450 metabolites of arachidonic acid
92. Angiotensin II releases 20-HETE from rat renal microvessels
93. Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats
94. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses
95. B receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole
96. Role of guanylyl cyclase and cytochrome P-450 on renal response to nitric oxide
97. The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction
98. Identification of a putative microvascular oxygen sensor
99. 2 sensor in rat arterioles and skeletal muscle cells
100. Relative contributions of cyclooxygenase- and cytochrome P450 ω-hydroxylase-dependent pathways to hypoxic dilation of skeletal muscle resistance arteries
101. Altered mechanisms underlying hypoxic dilation of skeletal muscle resistance arteries of hypertensive versus normotensive Dahl rats
102. Role of prostanoids and 20-HETE in mediating oxygen-induced constriction of skeletal muscle resistance arteries
103. Impairment of flow-induced dilation of skeletal muscle arterioles with elevated oxygen in normotensive and hypertensive rats
104. 20-HETE modulates myogenic response of skeletal muscle resistance arteries from hypertensive Dahl-SS rats
105. Production of 20-HETE and its role in autoregulation of cerebral blood flow
106. Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries
107. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo
108. Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue
109. Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites
110. Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells
111. 20-Hydroxyeicosatetraenoic acid mediates angiotensin II-induced phospholipase D activation in vascular smooth muscle cells
112. 2 in response to norepinephrine
113. Role of 20-HETE in mediating the effect of dietary K intake on the apical K channels in the mTAL
114. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport
115. 16(R)-hydroxy-5,8,11,14-eicosatetraenoic acid, a new arachidonate metabolite in human polymorphonuclear leukocytes
116. CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract
117. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats
118. Angiotensin II-induced hypertension: Contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites
119. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension
120. 16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke